Development and validation of a recurrence risk assessment model for high-grade bladder cancer based on TCGA and GEO
The recurrence assessment model is a relatively accurate recurrence prediction tool for high-grade bladder cancer and could provide a guidance for the treatment of bladder cancer.
Authors
- Cheng Zhang (ORCID: https://orcid.org/0000-0003-1690-092X)
- Hongxin Wang (ORCID: https://orcid.org/0000-0001-5531-3109)
- LI Ming-shan (ORCID: https://orcid.org/0000-0002-1427-5190)
- Yuping Zheng (ORCID: https://orcid.org/0009-0001-1936-7625)
Institutions
- Fourth Affiliated Hospital of China Medical University (CN)
- China Medical University (CN)
Publication Details
- Journal
- Translational Cancer Research
- Published
- 2024-09-01
- DOI
- https://doi.org/10.21037/tcr-24-256
- Citations
- 1
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.57